(Foto: Jyrki Siikanen)
Prof. Ann-Christine Syvänen
Ann-Christine.Syvanen@medsci.uu.se
Address:
Molecular Medicine
Department of Medical Sciences
Entrance 70, 3rd floor
Research dept. II
University Hospital
SE-751 85 UPPSALA
The research group of Molecular Medicin and the SNP&SEQ Technology Platform at Uppsala University is located in the Research Department 2 & 3 at the Uppsala University Hospital, Entrance 70, 3rd floor.
Visiting address: Uppsala University Hospital
Entr. 70, 3rd floor, Res. Dept. 2 and 3
Uppsala, Sweden
(go here for SNP&SEQ Technology Platform contact information)
(Click image to enlarge)
2012-04-23
Large grant for epigenetic and genomic analyses of the brain from VR, FAS, Formas and Vinnova to Molecular Medicine and the SNP&SEQ platform.
2012-03-16
The SNP&SEQ Technology Platform has installed a MiSeq instrument from Illumina.
2011-12-14
Molecular Medicine research group has received funding from the Swedish Childhood Cancer Foundation.
2011-11-17
VR-RFI has granted 6.7 million SEK for running costs to the SNP&SEQ platform.
2011-10-04
Molecular Medicine research group has received funding from the K&A Wallenberg foundation.
2011-08-11
A study that doubles the number of susceptibility genes for multiple sclerosis (MS) was published in Nature on Aug 11.
2011-06-20
The SNP&SEQ Technology Platform have now upgraded our Genome Analyzer IIx with a HiSeq 2000 instrument from Illumina.
2011-03-06
Five new loci for coronary artery disease were published on-line in Nature Genetics on March 6th.
2011-01-18
The Molecular Medicine group contributes to the ESGI infra-structure by technology development, eg. allele-specific gene expression and epigenetics.
